PT863880E - Novas 1-ar(alqu)il-imidazolin-2-onas de efeito anticonvulsivo contendo um grupo amino dissubstituido na posicao 4 e processo para a sua producao - Google Patents

Novas 1-ar(alqu)il-imidazolin-2-onas de efeito anticonvulsivo contendo um grupo amino dissubstituido na posicao 4 e processo para a sua producao

Info

Publication number
PT863880E
PT863880E PT96927607T PT96927607T PT863880E PT 863880 E PT863880 E PT 863880E PT 96927607 T PT96927607 T PT 96927607T PT 96927607 T PT96927607 T PT 96927607T PT 863880 E PT863880 E PT 863880E
Authority
PT
Portugal
Prior art keywords
production
relates
present
amino acid
acid group
Prior art date
Application number
PT96927607T
Other languages
English (en)
Portuguese (pt)
Inventor
Hans-Joachim Lankau
Manfred Menzer
Klaus Unverferth
Karl Gewald
Harry Schafer
Original Assignee
Elbion Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT863880(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Elbion Ag filed Critical Elbion Ag
Publication of PT863880E publication Critical patent/PT863880E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT96927607T 1995-09-05 1996-07-26 Novas 1-ar(alqu)il-imidazolin-2-onas de efeito anticonvulsivo contendo um grupo amino dissubstituido na posicao 4 e processo para a sua producao PT863880E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (de) 1995-09-05 1995-09-05 Neue, antikonvulsiv wirkende 1-Ar(alk)yl-imidazolin-2-one, die in 4-Stellung einen disubstituierten Amin-Rest enthalten, und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
PT863880E true PT863880E (pt) 2004-04-30

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96927607T PT863880E (pt) 1995-09-05 1996-07-26 Novas 1-ar(alqu)il-imidazolin-2-onas de efeito anticonvulsivo contendo um grupo amino dissubstituido na posicao 4 e processo para a sua producao

Country Status (31)

Country Link
EP (1) EP0863880B1 (https=)
JP (1) JP4030578B2 (https=)
CN (1) CN1103762C (https=)
AR (1) AR003502A1 (https=)
AT (1) ATE254606T1 (https=)
AU (1) AU700602B2 (https=)
BG (1) BG63917B1 (https=)
BR (1) BR9610359A (https=)
CA (1) CA2184871C (https=)
CZ (1) CZ291839B6 (https=)
DE (2) DE19532668A1 (https=)
DK (1) DK0863880T3 (https=)
EA (1) EA000535B1 (https=)
EE (1) EE03562B1 (https=)
ES (1) ES2208758T3 (https=)
FR (1) FR13C0049I2 (https=)
GE (1) GEP20022652B (https=)
HU (1) HU225956B1 (https=)
IL (1) IL123333A (https=)
LT (1) LT4482B (https=)
LU (1) LU92263I2 (https=)
NO (1) NO313829B1 (https=)
NZ (1) NZ315624A (https=)
PL (1) PL188287B1 (https=)
PT (1) PT863880E (https=)
SK (1) SK284868B6 (https=)
TR (1) TR199800476T1 (https=)
TW (1) TW422838B (https=)
UA (1) UA46790C2 (https=)
WO (1) WO1997009314A1 (https=)
ZA (1) ZA967014B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (de) * 1997-05-23 1998-11-26 Dresden Arzneimittel Verwendung von 1-Ar(alk)yl-imidazolin-2-one zur Behandlung von Angst- und Spannungszuständen
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
RU2354377C2 (ru) * 2003-07-11 2009-05-10 Берингер Ингельхайм Ветмедика Гмбх Способ лечения или предупреждения заболеваний центральной нервной системы с использованием соединений, обладающих селективностью в отношении альфа-3-субъединицы бензодиазепинового рецептора
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
WO2013024036A1 (en) 2011-08-12 2013-02-21 Boehringer Ingelheim Vetmedica Gmbh Funny current (if) inhibitors for use in a method of treating and preventing heart failure in feline
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (it) 2021-01-18 2022-07-18 Procos Spa Processo per la sintesi di imepitoina
EP4553066A1 (en) 2023-11-10 2025-05-14 Justesa Imagen S.A.U. Improved process for the synthesis of imepitoin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (fr) 1971-10-21 1973-04-20 American Cyanamid Co Nouvelles (p-chloro) phenyl-1 methyl-3 imidazolidines, 2,4-disubstituees utiles notamment comme agents diuretiques antialdosterone et leur procede de preparation
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
ES2208758T3 (es) 2004-06-16
LT4482B (lt) 1999-03-25
ATE254606T1 (de) 2003-12-15
MX9801742A (es) 1998-08-30
JP4030578B2 (ja) 2008-01-09
EA000535B1 (ru) 1999-10-28
GEP20022652B (en) 2002-03-25
HUP9802941A2 (hu) 1999-09-28
LU92263I2 (fr) 2013-10-07
AR003502A1 (es) 1998-08-05
PL188287B1 (pl) 2005-01-31
EP0863880A1 (de) 1998-09-16
CA2184871C (en) 2001-08-21
SK21698A3 (en) 1998-10-07
JPH11512101A (ja) 1999-10-19
HU225956B1 (en) 2008-01-28
CN1200728A (zh) 1998-12-02
HK1015776A1 (en) 1999-10-22
EA199800271A1 (ru) 1998-10-29
FR13C0049I2 (fr) 2014-03-28
LT98047A (en) 1998-10-26
NZ315624A (en) 1998-11-25
EP0863880B1 (de) 2003-11-19
CA2184871A1 (en) 1997-03-06
DE19532668A1 (de) 1997-03-06
NO980906D0 (no) 1998-03-02
PL325413A1 (en) 1998-07-20
BR9610359A (pt) 1999-07-06
NO980906L (no) 1998-03-02
EE03562B1 (et) 2001-12-17
CZ291839B6 (cs) 2003-06-18
IL123333A0 (en) 1998-09-24
TR199800476T1 (xx) 1998-06-22
AU6737596A (en) 1997-03-27
CN1103762C (zh) 2003-03-26
SK284868B6 (sk) 2006-01-05
AU700602B2 (en) 1999-01-07
WO1997009314A1 (de) 1997-03-13
BG63917B1 (bg) 2003-06-30
DK0863880T3 (da) 2004-03-22
HUP9802941A3 (en) 1999-10-28
DE59610827D1 (de) 2003-12-24
NO313829B1 (no) 2002-12-09
IL123333A (en) 2001-10-31
ZA967014B (en) 1997-08-18
BG102287A (en) 1998-09-30
TW422838B (en) 2001-02-21
UA46790C2 (uk) 2002-06-17
FR13C0049I1 (https=) 2013-09-27
CZ66198A3 (cs) 1998-07-15
EE9800063A (et) 1998-08-17

Similar Documents

Publication Publication Date Title
BR9611922A (pt) Composição solvente de elevada pureza e processo para a sua produção
BR9505051A (pt) Composto derivado de 2,4-oxazolidinodiona processo para a sua produção e composição farmacêutica
BR8501322A (pt) Produto de filtracao fibroso moldado,e,processo para sua preparacao
BR9103767A (pt) Maquina de fabricacao de condutores e processo para sua fabricacao
BR9605710A (pt) Processo para a obtençao e recuperaçao de ácidos
BR8905850A (pt) Eletrodo de cadmio e processo para sua producao
BR8707744A (pt) Arvore de manivelas e processo para a sua producao
BR9609182A (pt) Processo de hidrólise contínua para preparação de ácido-2-hidroxi-4-metiltiobutanóico ous sais do mesmo
PT863880E (pt) Novas 1-ar(alqu)il-imidazolin-2-onas de efeito anticonvulsivo contendo um grupo amino dissubstituido na posicao 4 e processo para a sua producao
BR9000446A (pt) Uniao tubular e processo para sua producao
FI822065A7 (fi) Menetelmä aspartiinihapon ja glutamiinihapon täydelliseksi tai osittaiseksi poistamiseksi proteiiniproteiinihydrolyysisaasteista ja aminohapposeoksista sekä näin saadut aminohapposeokset.
BR9300521A (pt) Processo de fabricação de chapas refletivas ou de sinalização e produto resultante.
PT1015433E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua producao e sua utilizacao como medicamentos
BR9003385A (pt) Processo para a producao de proteinas vegetais hidrolisadas,produto e proteina vegetal hidrolisada
BR9401490A (pt) Composição de xampu e processo para sua produção
BR8502921A (pt) Barra de detergente macica,processo para sua fabricacao e composicao detergente-amaciante
BR9005935A (pt) Barra de detergente e processo para a sua fabricacao
BR9602032A (pt) Processo de fabricação de 1,1-difluoroetano
BR9506425A (pt) Poliacetal modificado e processo para a sua produçao
IT8521428A0 (it) Processo perfezionato di transaminazione per la produzionedi aminoacidi.
BR9509367A (pt) Processo para preparar amidas ácidas
BR9005385A (pt) Processo para a producao de 1,1-diclorotetrafluoretano
BR9611214A (pt) Composição aquosa para amaciamento de tecido e processo para sua preparação
BR9707168A (pt) Barrade sabão transparente e processo para sua produção
BR9104428A (pt) Copolimero por blocos elastomero e processo para a sua producao